Urinary Tract Cancer Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194232 | Category: Medical Devices & Consumables | Pages: 60 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Surgery to remove the cancer is the most common treatment for cancer of the urethra. One of the following types of surgery may be done: Open excision: Removal of the cancer by surgery. Transurethral resection (TUR): Surgery to remove the cancer using a special tool inserted into the urethra.
This report aims to provide a comprehensive presentation of the global market for Urinary Tract Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Tract Cancer Treatment. This report contains market size and forecasts of Urinary Tract Cancer Treatment in global, including the following market information:
Global Urinary Tract Cancer Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Urinary Tract Cancer Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Open Excision Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Urinary Tract Cancer Treatment include Astellas Pharma Inc, Eli Lilly and Company, Endo International Plc, Exelixis Inc, GlaxoSmith Plc, Merck KGaA, Novartis AG, Pfizer Inc and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urinary Tract Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urinary Tract Cancer Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Urinary Tract Cancer Treatment Market Segment Percentages, by Type, 2022 (%)
    Open Excision
    Transurethral Resection (TUR)
    Others
Global Urinary Tract Cancer Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Urinary Tract Cancer Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospital
    Clinics
    Others
Global Urinary Tract Cancer Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Urinary Tract Cancer Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urinary Tract Cancer Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Urinary Tract Cancer Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Astellas Pharma Inc
    Eli Lilly and Company
    Endo International Plc
    Exelixis Inc
    GlaxoSmith Plc
    Merck KGaA
    Novartis AG
    Pfizer Inc
    Johnson & Johnson
    Bristol-Myers Squibb Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urinary Tract Cancer Treatment, market overview.
Chapter 2: Global Urinary Tract Cancer Treatment market size in revenue.
Chapter 3: Detailed analysis of Urinary Tract Cancer Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urinary Tract Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Urinary Tract Cancer Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Urinary Tract Cancer Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Urinary Tract Cancer Treatment Overall Market Size
    2.1 Global Urinary Tract Cancer Treatment Market Size: 2022 VS 2029
    2.2 Global Urinary Tract Cancer Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Urinary Tract Cancer Treatment Players in Global Market
    3.2 Top Global Urinary Tract Cancer Treatment Companies Ranked by Revenue
    3.3 Global Urinary Tract Cancer Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Urinary Tract Cancer Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Urinary Tract Cancer Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Urinary Tract Cancer Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Urinary Tract Cancer Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Urinary Tract Cancer Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Urinary Tract Cancer Treatment Market Size Markets, 2022 & 2029
        4.1.2 Open Excision
        4.1.3 Transurethral Resection (TUR)
        4.1.4 Others
    4.2 By Type - Global Urinary Tract Cancer Treatment Revenue & Forecasts
        4.2.1 By Type - Global Urinary Tract Cancer Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Urinary Tract Cancer Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Urinary Tract Cancer Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Urinary Tract Cancer Treatment Market Size, 2022 & 2029
        5.1.2 Hospital
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Urinary Tract Cancer Treatment Revenue & Forecasts
        5.2.1 By Application - Global Urinary Tract Cancer Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Urinary Tract Cancer Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Urinary Tract Cancer Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Urinary Tract Cancer Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Urinary Tract Cancer Treatment Revenue & Forecasts
        6.2.1 By Region - Global Urinary Tract Cancer Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Urinary Tract Cancer Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Urinary Tract Cancer Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Urinary Tract Cancer Treatment Revenue, 2018-2029
        6.3.2 US Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.3.3 Canada Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.3.4 Mexico Urinary Tract Cancer Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Urinary Tract Cancer Treatment Revenue, 2018-2029
        6.4.2 Germany Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.3 France Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.4 U.K. Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.5 Italy Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.6 Russia Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.4.8 Benelux Urinary Tract Cancer Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Urinary Tract Cancer Treatment Revenue, 2018-2029
        6.5.2 China Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.5.3 Japan Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.5.4 South Korea Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.5.6 India Urinary Tract Cancer Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Urinary Tract Cancer Treatment Revenue, 2018-2029
        6.6.2 Brazil Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.6.3 Argentina Urinary Tract Cancer Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Urinary Tract Cancer Treatment Revenue, 2018-2029
        6.7.2 Turkey Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.7.3 Israel Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Urinary Tract Cancer Treatment Market Size, 2018-2029
        6.7.5 UAE Urinary Tract Cancer Treatment Market Size, 2018-2029
7 Urinary Tract Cancer Treatment Companies Profiles
    7.1 Astellas Pharma Inc
        7.1.1 Astellas Pharma Inc Company Summary
        7.1.2 Astellas Pharma Inc Business Overview
        7.1.3 Astellas Pharma Inc Urinary Tract Cancer Treatment Major Product Offerings
        7.1.4 Astellas Pharma Inc Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.1.5 Astellas Pharma Inc Key News & Latest Developments
    7.2 Eli Lilly and Company
        7.2.1 Eli Lilly and Company Company Summary
        7.2.2 Eli Lilly and Company Business Overview
        7.2.3 Eli Lilly and Company Urinary Tract Cancer Treatment Major Product Offerings
        7.2.4 Eli Lilly and Company Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.2.5 Eli Lilly and Company Key News & Latest Developments
    7.3 Endo International Plc
        7.3.1 Endo International Plc Company Summary
        7.3.2 Endo International Plc Business Overview
        7.3.3 Endo International Plc Urinary Tract Cancer Treatment Major Product Offerings
        7.3.4 Endo International Plc Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.3.5 Endo International Plc Key News & Latest Developments
    7.4 Exelixis Inc
        7.4.1 Exelixis Inc Company Summary
        7.4.2 Exelixis Inc Business Overview
        7.4.3 Exelixis Inc Urinary Tract Cancer Treatment Major Product Offerings
        7.4.4 Exelixis Inc Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.4.5 Exelixis Inc Key News & Latest Developments
    7.5 GlaxoSmith Plc
        7.5.1 GlaxoSmith Plc Company Summary
        7.5.2 GlaxoSmith Plc Business Overview
        7.5.3 GlaxoSmith Plc Urinary Tract Cancer Treatment Major Product Offerings
        7.5.4 GlaxoSmith Plc Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.5.5 GlaxoSmith Plc Key News & Latest Developments
    7.6 Merck KGaA
        7.6.1 Merck KGaA Company Summary
        7.6.2 Merck KGaA Business Overview
        7.6.3 Merck KGaA Urinary Tract Cancer Treatment Major Product Offerings
        7.6.4 Merck KGaA Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.6.5 Merck KGaA Key News & Latest Developments
    7.7 Novartis AG
        7.7.1 Novartis AG Company Summary
        7.7.2 Novartis AG Business Overview
        7.7.3 Novartis AG Urinary Tract Cancer Treatment Major Product Offerings
        7.7.4 Novartis AG Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.7.5 Novartis AG Key News & Latest Developments
    7.8 Pfizer Inc
        7.8.1 Pfizer Inc Company Summary
        7.8.2 Pfizer Inc Business Overview
        7.8.3 Pfizer Inc Urinary Tract Cancer Treatment Major Product Offerings
        7.8.4 Pfizer Inc Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.8.5 Pfizer Inc Key News & Latest Developments
    7.9 Johnson & Johnson
        7.9.1 Johnson & Johnson Company Summary
        7.9.2 Johnson & Johnson Business Overview
        7.9.3 Johnson & Johnson Urinary Tract Cancer Treatment Major Product Offerings
        7.9.4 Johnson & Johnson Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.9.5 Johnson & Johnson Key News & Latest Developments
    7.10 Bristol-Myers Squibb Company
        7.10.1 Bristol-Myers Squibb Company Company Summary
        7.10.2 Bristol-Myers Squibb Company Business Overview
        7.10.3 Bristol-Myers Squibb Company Urinary Tract Cancer Treatment Major Product Offerings
        7.10.4 Bristol-Myers Squibb Company Urinary Tract Cancer Treatment Revenue in Global Market (2018-2023)
        7.10.5 Bristol-Myers Squibb Company Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Urinary Tract Cancer Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?